first in human phase 1 study to support the early diagnosis and clinical management of Parkinson's disease

Trial Profile

first in human phase 1 study to support the early diagnosis and clinical management of Parkinson's disease

Planning
Phase of Trial: Phase I

Latest Information Update: 27 Mar 2018

At a glance

  • Drugs Tau PET imaging agents-AC Immune/Piramal Imaging (Primary)
  • Indications Parkinson's disease
  • Focus Adverse reactions; Diagnostic use; First in man
  • Most Recent Events

    • 27 Mar 2018 New trial record
    • 20 Mar 2018 According to an AC Immune media release, company commenced this study in the the second half of 2018.
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top